07.01.04
Integrity Nutraceuticals International (INI) has launched Cinnulin PF™, a proprietary cinnamon extract developed to support healthy glucose levels and insulin response. According to a recent study appearing in Diabetes Care, cinnamon extract showed great potential for formulas that address diabetic conditions, such as type II diabetes. Study subjects consuming cinnamon for 40 days demonstrated marked decreases in fasting glucose, between 18-29%, as well as decreases in cholesterol (12-26%) and triglycerides (23-30%), according to the company. To further drive research and development of cinnamon extract, INI has formed two strategic partnerships. INI has partnered with Beijing Tang-An Medical to market U.S. Patent #6,200,569. This patented method retains the bioactive compounds and omits any possible toxins occurring in whole cinnamon. INI has also formed an exclusive relationship with the United States Department of Agriculture (USDA) to further the body of knowledge on cinnamon.